Synthesis and characterization of poly D-L lactide (PLA) nanoparticles for the delivery of quercetin

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 5, 2015, Pages 42-49

  Sambandam, Bharathi ^a   Kumar S, Sathesh ^b   Ayyaswamy, Arivarasan ^a   Yadav Bv, Nagarjuna ^b   Thiyagarajan, Devasena ^a  

^a ANNA UNIVERSITY   (India)

^b VELS INSTITUTE OF SCIENCE   (India)

Author keywords

Antioxidant; Nanoprecipitation; PLA nanoparticles; Quercetin

Indexed keywords

NANOPARTICLE; POLYLACTIDE NANOPARTICLE; QUERCETIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; DIFFERENTIAL SCANNING CALORIMETRY; DPPH RADICAL SCAVENGING ASSAY; DRUG RELEASE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 84929453900     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B 2010;80:184-92.
2. Nuengchamnong N, Hermans-Lokkerbol A, Ingkaninan K. Separation and detection of the antioxidant flavonoids, rutin and quercetin, using HPLC coupled on-line with colorimetric detection of antioxidant activity. Naresuan Univ J 2004;12:25–37.
3. Sorata Y, Takahama U, Kimura M. Protective effect of quercetin and rutin on photosensitized lysis of human erythrocytes in the presence of hematoporphyrin. Biochim Biophy Acta 1984;799:313-7.
4. Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. J Nutr 2008;24:703-10.
5. Borska S, Gebarowska E, Wysocka T, Drag-Zalesinska M, Zabel M. The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions. Folia Morphol 2004;63:103-5.
6. Saito A, Sugisawa A, Umegaki K, Sunagawa H. Protective effects of quercetin and its metabolites on H2O2-induced chromosomal damage to WIL2-NS cells. Biosci Biotech Bioch 2004;68:271-6.
7. Moskaug JØ, Carlsen H, Myhrstad M, Blomhoff R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev 2004;125:315-24.
8. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships. Free Radic Biol Med 1997;22:749-60.
9. Pralhad T, Rajendrakumar K. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 2004;34:333-9.
10. Makris DP, Rossiter JT. Quercetin and rutin (quercetin 3-O-rhamnosylglucoside) thermal degradation in aqueous media under alkaline condition. In: Buttriss J, Saltmarsh M, Editors. Functional Foods-Claims and Evidence. Royal Society of Chemistry Press: London, UK; 2000. p. 216-38.
11. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999;37:937-42.
12. Middleton EJ. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998;439:175-82.
13. Huk I, Brovkovych V, Nanobash VJ, Weigel G, Neumayer C, Partyka L, et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg 1998;85:1080-5.
14. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
15. Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 1998;66:147-52.
16. Dunnick JK, Hailey JR. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 1992;19:423-31.
17. Korkina LG, Afanas’ev IB. Antioxidant and chelating properties of Flavonoids. Adv Pharmacol 1997;38:151-63.
18. Hollman PC, Van Trijp JM, Mengelers MJ, de VriesJH, Katan MB. Bioavailability of the dietary antioxidant flavonolquercetin in man. Cancer Lett 1997;114:139-40.
19. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, et al. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 1999;69:87-94.
20. Lee SH, Zhang Z, Feng SS. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA–PGS) copolymers for protein drug delivery. Biomaterials 2007;28:2041-50.
21. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliver Rev 2002;54:631-51.
22. Yuan F, Leuning M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenograft. Cancer Res 1994;54:3352-3356.
23. Lemos-Sennaa E, Wouessidjeweb D, Lesieura S, Duchênea D. Preparation of amphiphiliccyclodextrinnanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. Int J Pharm 1998;170:119-28.
24. Vinogradov S, Batrakova E, Kabanov A. Poly(ethylene glycol)-polyethyleneimine Nano Gel TM particles: novel drug delivery systems for antisense oligonucleotides. Colloid Surf B 1999;16:291-304.
25. Priprem A, Watanatorn J, Sutthiparinyanont S, Phachonpai W, Muchimapura S. Anxiety and cognitive effects of quercetin liposomes in rats. Nanomed 2008;4:70-8.
26. Zhang Y, Yang Y, Tang K, Hu X, Zou G. Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 2008;107:891-7.
27. Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC, Cham TM. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 2008;346:160-8.
28. Mehrotra P. Critical process parameters evaluation of modified nanoprecipitation method on lomustine nanoparticles and cytostatic activity study on L132 human cancer cell line. J Nanomed Nanotechnol 2012;3:1-8.
29. Kumar N, Bhandari P, Singh B, Bari SS. Antioxidant activity and ultra-performance LC-electrospray ionization-quadrupole time-of-flight mass spectrometry for phenolics-based fingerprinting of Rose species: Rosa damascena, Rosa bourboniana and Rosa brunonii. Food Chem Toxicol 2009;47:361-7.
30. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998;24:1113-28.
31. Eerikainen H, Kauppine EI. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. Int J Pharm 2003;263:69-83.
32. Borghetti GS, Lula IS, Sinisterra RD, Bassani VL. Quercetin/β-Cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture. AAPS Pharm Sci Tech 2009;10:235-42.
33. Olejniczak S, Potrzebowski MJ. Solid state NMR studies and density functional theory (DFT) calculations of conformers of quercetin. Org Biomol Chem 2004;2:2315-22.
34. Mainardes RM, Gremiao MPD, Evangelista RC. Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Braz J Pharm Sci 2006;42:523-30.
35. Corrigan OI, Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci 2009;37:477-85.
36. Joshi SA, Chavhan SS, Sawant KK. Rivastigmineloaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm 2010;76:189-99.
37. Mohanraj VJ, Chen Y. Nanoparticles: A review. Trop J Pharm Res 2006;5:561-73.
38. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres on the phagocytosis by macrophages. J Control Release 2002;79:29-40.
39. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticles formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004;21:1428-39.
40. Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, et al. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2008;69:445-53.
41. Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm 2008;350:320-9.
42. Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2008;17:247-89.
43. Chen J, Tian B, Yin X, Zhang Y, Hu D, Hu Z, et al. Preparation, characterization and transfection efficiency of cationic PE Gylated PLA nanoparticles as gene delivery systems. J Biotech 2007;130:107-13.
44. Qi L, Xu Z, Jiang X, Hu C, Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 2004;339:2693-700.
45. Hu J, Johnston KP, Williams RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004;30:233-45.
46. Muthu MS, Singh S. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomed 2008;3:305-19.
47. Gao H, Yang YW, Fan YG, Ma JB. Conjugates of poly (DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems. J Control Release 2006;112:301-11.
48. Michailova V, Berlinova I, Iliev P, Ivanov L, Titeva S, Momekov G, et al. Nanoparticles formed from PNIPAM-g-PEO copolymers in the presence of indomethacin. Int J Pharm 2010;384:154-64.
49. Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MN. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 2007;24:899-908.
50. Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, et al. Defining the drug incorporation properties of PLA–PEG nanoparticles. Int J Pharm 2000;199:95-110.
51. Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci 2004;93:1804-14.
52. Leo E, Brina B, Forni F, Vandelli MA. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int J Pharm 2004;278:133-41.
53. Riihimaki LH, Vainio MJ, Heikura JMS, Valkonen KH, Virtanen VT, Vuorela PM. Binding of phenolic compounds and their derivatives to bovine and reindeer b-lactoglobulin. J Agric Food Chem 2008;56:7721-9.
54. Pool H, Quintanar D, Figueroa JD, Mano CM, Bechara JEH, Godinez LA, et al. Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J Nanomater 2010;2012:145-380.
55. Sahoo NG, Kakran M, Shaal LA, Li L, Muller RH, Pal M, et al. Preparation and characterization of Quercetin nanocrystals. J Pharm Sci 2011;100(6):2379-90.